Position in AZN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$437,214,454
New position
Shares Held
2,216,887
first reported quarter
Ownership
0.143%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 71.4064812505103.ToString("F0")%
Shared 0.ToString("F0")%
None 28.59351874948971.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026LAZARD ASSET MANAGEMENT LLC holds $2,038,524,902 across 14 Drug Manufacturers - General names. AZN ranks #2 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
718,105 | $660,491,434 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
2,216,887 | $437,214,454 | |
| 3 | MRK |
Merck & Co., Inc.
|
3,254,331 | $391,463,475 | |
| 4 | JNJ |
Johnson & Johnson
|
1,302,952 | $318,493,585 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,924,036 | $116,692,783 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
299,734 | $41,773,927 | |
| 7 | ABBV |
AbbVie Inc.
|
157,597 | $34,275,771 | |
| 8 | AMGN |
Amgen Inc
|
50,478 | $17,760,684 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $437,214,454 | 2,216,887 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||